These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
653 related items for PubMed ID: 29043431
1. 99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer. Wondergem M, van der Zant FM, Knol RJJ, Burgers AMG, Bos SD, de Jong IJ, Pruim J. World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431 [Abstract] [Full Text] [Related]
8. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT. Usmani S, Marafi F, Ahmed N, Esmail A, Al Kandari F, Van den Wyngaert T. Clin Nucl Med; 2017 Nov; 42(11):829-836. PubMed ID: 28872551 [Abstract] [Full Text] [Related]
10. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Langsteger W, Rezaee A, Pirich C, Beheshti M. Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429 [Abstract] [Full Text] [Related]
11. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, Tamaki N, Schwaiger M, Maurer T, Eiber M. Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2114-2121. PubMed ID: 27290607 [Abstract] [Full Text] [Related]
12. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635 [Abstract] [Full Text] [Related]
13. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer]. Garcia JR, Moreno C, Valls E, Cozar P, Bassa P, Soler M, Alvarez-Moro FJ, Moragas M, Riera E. Rev Esp Med Nucl Imagen Mol; 2015 Feb; 34(3):155-61. PubMed ID: 25443648 [Abstract] [Full Text] [Related]
14. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF, Chen CY, Cheng MF, Wu YW, Shiau YC, Wu K, Hong RL, Yu CJ, Wang KL, Yang RS. Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259 [Abstract] [Full Text] [Related]
17. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL, Xue YL, Song HJ, Luo QY. Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353 [Abstract] [Full Text] [Related]
18. Accuracy of 18F-NaF PET/CT in bone metastasis detection and its effect on patient management in patients with breast carcinoma. Broos WAM, van der Zant FM, Wondergem M, Knol RJJ. Nucl Med Commun; 2018 Apr; 39(4):325-333. PubMed ID: 29351123 [Abstract] [Full Text] [Related]
19. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP. Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W. Hell J Nucl Med; 2017 Apr; 20(3):237-240. PubMed ID: 29177262 [Abstract] [Full Text] [Related]
20. Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Zhou J, Gou Z, Wu R, Yuan Y, Yu G, Zhao Y. Skeletal Radiol; 2019 Dec; 48(12):1915-1924. PubMed ID: 31127357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]